Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study.

导出 OA

翻译打印收藏纠错

第一作者： Asahiro,Morishita

第一单位： Department of Gastroenterology and Neurology, Kagawa University, Kita-gun, Kagawa, 761-0793, Japan. morishita.asahiro@kagawa-u.ac.jp.

作者： Asahiro,Morishita ^[1] ; Kyoko,Oura ^[2] ; Kei,Takuma ^[2] ; Mai,Nakahara ^[2] ; Tomoko,Tadokoro ^[2] ; Koji,Fujita ^[2] ; Joji,Tani ^[2] ; Tingting,Shi ^[2] ; Takashi,Himoto ^[3] ; Miwa,Tatsuta ^[4] ; Akio,Moriya ^[5] ; Tomonori,Senoo ^[6] ; Akemi,Tsutsui ^[6] ; Takuya,Nagano ^[6] ; Koichi,Takaguchi ^[6] ; Masafumi,Ono ^[2] ; Tsutomu,Masaki ^[2]

作者单位： Department of Gastroenterology and Neurology, Kagawa University, Kita-gun, Kagawa, 761-0793, Japan. morishita.asahiro@kagawa-u.ac.jp. ^[1] Department of Gastroenterology and Neurology, Kagawa University, Kita-gun, Kagawa, 761-0793, Japan. ^[2] Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Japan. ^[3] Department of Gastroenterology, KKR Takamatsu Hospital, Takamatsu, Japan. ^[4] Department of Gastroenterology, Mitoyo General Hospital, Kanonji, Japan. ^[5] Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan. ^[6]

关键词 FAST score Fibrotic biomarkers Hypertriglyceridemia NAFLD Pemafibrate

主题词人类(Humans);回顾性研究(Retrospective Studies);肝硬化(Liver Cirrhosis);纤维化(Fibrosis);高甘油三酯血症(Hypertriglyceridemia);天冬氨酸氨基转移酶类(Aspartate Aminotransferases);胆固醇(Cholesterol)

DOI 10.1007/s12072-022-10453-1

PMID 36583842

发布时间 2023-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交